cc-5013
Showing 1 - 18 of 18
Multiple Myeloma Trial in Russian Federation, Ukraine (CC-5013, Lenalidomide)
Myelodysplastic Syndrome Trial in Tucson (CC-5013)
Completed
- Myelodysplastic Syndrome
- CC-5013
-
Tucson, ArizonaArizona Cancer Center
Nov 6, 2019
Multiple Myeloma Trial in United States (CC-5013)
Completed
- Multiple Myeloma
- CC-5013
-
Glendale, Arizona
- +25 more
Nov 7, 2019
Malignant Melanoma Trial in Houston (CC-5013)
Completed
- Malignant Melanoma
- CC-5013
-
Houston, TexasMD Anderson Cancer Center
Nov 6, 2019
Melanoma, Tumor Metastasis Trial in Worldwide (CC-5013)
Completed
- Melanoma
- Neoplasm Metastasis
- CC-5013
-
Garran, Australian Capital Territory, Australia
- +48 more
Nov 6, 2019
Multiple Myeloma Trial in Cleveland (CC-5013)
Completed
- Multiple Myeloma
- CC-5013
-
Cleveland, OhioCleveland Clinic Myeloma Program
Nov 30, 2016
Crohn's Disease Trial in Worldwide (CC-5013)
Completed
- Crohn's Disease
- CC-5013
-
Tucson, Arizona
- +19 more
Nov 30, 2016
Refractory Multiple Myeloma, Relapsed Multiple Myeloma, Multiple Myeloma Trial in United States (Bortezomib, CC-5013)
Completed
- Refractory Multiple Myeloma
- +2 more
- Bortezomib
- CC-5013
-
Tampa, Florida
- +5 more
Jan 21, 2016
MDS Trial in Worldwide (CC-5013)
Completed
- Myelodysplastic Syndromes
- CC-5013
-
Scottsdale, Arizona
- +118 more
Apr 3, 2013
Amyloidosis Trial in Rochester (CC-5013)
Completed
- Amyloidosis
- CC-5013
-
Rochester, MinnesotaMayo Clinic
May 5, 2011
Multiple Myeloma Trial in Little Rock (CC-5013)
Completed
- Multiple Myeloma
- CC-5013
-
Little Rock, ArkansasMyeloma Institute University of Arkansas for Medical Sciences
Sep 22, 2009
NSCLC Trial in United States (CC-5013)
Completed
- Non-Small Cell Lung Cancer
- CC-5013
-
Birmingham, Alabama
- +5 more
Dec 19, 2006
Ovarian Cancer Trial in United States (CC-5013, liposomal doxorubicin)
Terminated
- Ovarian Cancer
- CC-5013
- liposomal doxorubicin
-
San Francisco, California
- +4 more
Apr 10, 2006